Loading...
 
Translate Register Log In Login with facebookLogin and Register

Lower risk of Heart Disease associated with higher levels of vitamin D – June 2013

Plasma vitamin D and biomarkers of cardiometabolic disease risk in adult Canadians, 2007-2009.

Prev Chronic Dis. 2013 Jun 6;10:E91. doi: 10.5888/pcd10.120230.
García-Bailo B1, Da Costa LA, Arora P, Karmali M, El-Sohemy A, Badawi A.
Department of Nutritional Sciences, University of Toronto, and Office of Biotechnology and Population Health, Public Health Agency of Canada, Toronto, Canada.

Image
INTRODUCTION:
Vitamin D may modulate cardiometabolic disease risk, although the relationship has not been investigated in the general Canadian population. Understanding this relationship may inform public health strategies to curb the incidence of cardiometabolic disease in Canada and elsewhere. The objectives of this study were to examine the association between vitamin D and traditional and novel biomarkers of cardiometabolic disease and to describe the extent of the month-to-month fluctuations of vitamin D in the Canadian population.

METHODS:
We examined the association between plasma 25-hydroxyvitamin D and a range of cardiometabolic risk biomarkers in participants (n = 1,928; age range, 16-79 years) from the Canadian Health Measures Survey. We conducted linear regressions analyses (adjusted for sex, waist circumference, physical activity, hormone use, and season) to assess the relationship between 25-hydroxyvitamin D and biomarkers of dysglycemia, dyslipidemia, and inflammation in the study population. We repeated analyses stratified by sex, and we evaluated monthly fluctuations in 25-hydroxyvitamin D in men and women.

RESULTS:
We observed wide month-to-month variations in 25-hydroxyvitamin D; fluctuations were more pronounced in men. Plasma 25-hydroxyvitamin D was inversely associated with insulin, insulin resistance, triglycerides, total cholesterol, low-density lipoprotein cholesterol, and the ratio of total to high-density lipoprotein cholesterol but not with fasting glucose, apolipoprotein A1, apolipoprotein B, C-reactive protein, fibrinogen, or homocysteine. This pattern varied between men and women.

CONCLUSION:
Vitamin D may modulate various metabolic processes and may influence cardiometabolic disease risk in Canadians. These findings may have public health implications when recommending vitamin D for the prevention of cardiometabolic disease and related conditions.

PMID: 23742939


PDF is attached at the bottom of this page

See also VitaminDWiki

http://vitamindwiki.com/tiki-index.php?page_id=5240

Attached files

ID Name Comment Uploaded Size Downloads
3789 biomarkers ng.jpg admin 10 Apr, 2014 14:03 98.18 Kb 900
3787 Biomarkers of Cardiometabolic.pdf PDF 2013 admin 10 Apr, 2014 13:50 255.13 Kb 422
See any problem with this page? Report it (FINALLY WORKS)